News

Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...
A court-appointed special master recommended a bid backed by Gold Reserve and Koch over a rival hedge-fund offer. Krispy Kreme's top finance executive, Jeremiah Ashukian, is leaving the doughnut maker ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
The actor is raising awareness of clinical trials for cancer in partnership with “GMA” sponsor Eli Lilly & Co.
Eli Lilly and Company (NYSE: LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...
While Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...
Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...
LILLY — Winning pitcher P.J. Holberg scattered five hits in pitching Lilly Chiropractic to a 14-4 win over Refresh Med Spa in a Greater Altoona City League game Wednesday. Jake Hillard, Cody Gallaher ...
Since the city's establishment in the 1820s, Indianapolis has been a magnet for immigrants seeking opportunity and refuge.
The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...